Market news
Stocks and crypto headlines from Alpaca. Stored for 7 days. Total: 9742.
-
These Analysts Revise Their Forecasts On AMD After Q3 ResultsAMD beat Q3 revenue and earnings estimates, forecast strong Q4 growth, and saw mixed analyst price-target changes.
-
USDC Issuer Circle Quietly Cuts 5% of Staff in Profitable QuarterThe USDC issuer disclosed the cuts in its earnings release, booking $9.1 million in restructuring costs as reserve income fell 8%.
-
Bernstein raises TSMC price target to $600 from $554Bernstein's TSMC target hike underscores the semiconductor industry's supercycle, driven by AI demand and diverse customer growth. The post Bernstein raises TSMC price target to $600 from $554 appeared first on Crypto Briefing .
-
Why South Korea’s Largest US ETF Rallied While Seoul Sold Off — and What the Midterms Mean NextEWY gained 2.27% alongside chip ETFs before the midterm results. What does a Democratic sweep mean for the global AI trade?
-
Estée Lauder CEO Declares 'Best Is Yet To Come' With Ambitious 2030 Growth TargetsEstée Lauder (EL) stock rises after unveiling its 2030 targets and Beauty Reimagined plan following a strong Q1 earnings beat.
-
Block To Rally Around 54%? Here Are 10 Top Analyst Forecasts For WednesdayAnalysts raised targets for FRSH, EW, ATRC, SUPN and DUOL; cut targets for FLG and AMD. EW was upgraded, while FLG was downgraded.
-
Riot sells 20,264 Bitcoin for $1.5B to fund data center expansionRiot's strategic leases could enhance long-term growth, but managing debt and timely project execution are crucial for sustained success. The post Riot sells 20,264 Bitcoin for $1.5B to fund data center expansion appeared first on Crypto Briefing .
-
The New York Times Company Announces Third-Quarter 2026 Financial ResultsThe New York Times Company scheduled the release of its third-quarter 2026 financial results for November 4, 2026.
-
Circle beats earnings expectations on strong revenue, but cuts 5% of its workforceCircle’s net income for continuing operations of $226 million grew 5% year-over-year to $226 million in the third quarter.
-
Glaukos Insider Executes Significant Share SaleA Glaukos Corporation insider has sold shares valued at approximately $10.6 million, as disclosed in a recent SEC filing.
-
Analyst Adjusts Price Target for BioMarin Pharmaceutical Inc.An analyst has updated the 12-month price target for BioMarin Pharmaceutical Inc. to $90.85.
-
BTIG and Barclays Downgrade Driven BrandsAnalysts at BTIG and Barclays downgraded Driven Brands Holdings Inc. on November 4, 2026, following recent company disclosures regarding financial restatements and lowered earnings guidance.
-
Stella-Jones Reports Third Quarter 2026 Financial ResultsStella-Jones Inc. announced its financial results for the third quarter ended September 30, 2026, reporting sales of $979 million and adjusted EBITDA of $159 million.
-
Stella-Jones Announces Normal Course Issuer Bid and Quarterly DividendStella-Jones Inc. received approval for a new normal course issuer bid to repurchase up to 1.5 million common shares and declared a quarterly dividend of $0.34 per share.
-
BioCryst Pharmaceuticals Reports Third Quarter 2026 Financial ResultsBioCryst Pharmaceuticals, Inc. announced its financial results for the third quarter ended September 30, 2026, highlighting continued growth of its ORLADEYO therapy.
-
Graphic Packaging Launches Boardio™ Paperboard Packaging for Nutraceutical BrandsGraphic Packaging International, LLC has introduced its Boardio™ paperboard packaging solution, designed to help nutraceutical brands enhance on-shelf presence and sustainability.
-
Truist Securities Adjusts Price Target on Graphic PackagingTruist Securities has updated its price target for Graphic Packaging Holding Company to $10 from $9, while maintaining a "Hold" rating.
-
Barclays Maintains Hold Rating and $16 Price Target for The Chemours CompanyBarclays has reaffirmed its 'Hold' rating and $16 price target for The Chemours Company.
-
Enerpac Tool Group Hosts 2026 Investor Day and Unveils Propel StrategyEnerpac Tool Group held its 2026 Investor Day at the New York Stock Exchange, where leadership introduced the new 'Propel' strategy and established fiscal 2030 financial targets.
-
Addus HomeCare Corporation Analyst Price Target IncreasedAnalysts have raised the average 12-month price target for Addus HomeCare Corporation to $134.92.